investment

News

AstraZeneca cuts ribbon on new R&D facility in Massachusetts

AstraZeneca's has opened a new R&D centre in the biotech hotspot of Cambridge, Massachusetts, the centrepiece of a $1bn investment in the state.

News

Bayer pledges $2.2bn to US manufacturing facility

Bayer has joined the ranks of pharma groups planning major facility investments in the US, with a $2.2bn plan for a new production unit in Ohio.

News

Pharma leaders urge Europe to halt 'slow agony' of decline

Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."

Market Access

Due diligence: Identifying start-up risks & gaps

hVIVO's Consulting team discusses due diligence, a structured assessment process to evaluate an asset's risk, opportunities, and value drivers.

News

Pharma body sees 'green shoots' in UK investment

The UK is starting to benefit from a "real partnership" between pharma and government, reversing years of diminishing investment, says the ABPI.

Sales & Marketing

M&A trends in diagnostics and life sciences tools

The diagnostics and life sciences tools sector is attracting continued investor interest across both private equity and large corporates.

AstraZeneca cuts ribbon on new R&D facility in Massachusetts

Bayer pledges $2.2bn to US manufacturing facility

Pharma leaders urge Europe to halt 'slow agony' of decline

Due diligence: Identifying start-up risks & gaps

Pharma body sees 'green shoots' in UK investment

M&A trends in diagnostics and life sciences tools

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

investment

Editor's Picks